USFDA issues response letter for new drug application for insulin glargine: Biocon
As per the USFDA, a Complete Response Letter (CRL) is sent to an applicant if the agency determines that it will not approve the…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
insulin
Wockhardt gets exemption from price control for three insulin products
The three products have been classified as new drugs and thus qualify for non-application of the DPCO 2013 Drug price regulator…
Biocon inaugurates devices facility for insulin portfolio in Bangalore
The company also launches Basalog One, a ready to use insulin glargine disposable pen, for better blood sugar management Biocon…
More effective drugs for diabetes in the offing
Working in mice, the researchers showed they could reduce glucose production in the liver and lower blood sugar levels Scientists…
Human insulin market will reach $49,197.3 million in 2020 globally: Persistence Market Research
Asia Pacific to show fast growth rates in the next five years
Novo Nordisk launches Ryzodeg in India
The new treatment option aims at providing good glycaemic control with fewer injections than a basal-bolus regimen